Lipitor Met Its Match? Not So Fast, But AstraZeneca Gains Knowledge

Links shared publicly online about this topic.

27
total visits

Lipitor Met Its Match? Not So Fast, But AstraZeneca Gains Knowledge

Pharma giant AstraZeneca has declared that its cholesterol drug Crestor was not significantly better than Pfizer's Lipitor at preventing plaque from building up in one of the arteries that feed bl

View full resource at medicalnewstoday.com

Tags: Cholesterol, Cholesterol Medication, Drug, Pharma, Lipitor, Crestor, AstraZeneca

Most Recently Shared on September 4, 2011 at 7:18 am By:

Cholesterol OW

Lipitor Met Its Match? Not So Fast, But AstraZeneca Gains Knowledge: Pharma giant AstraZeneca has declared that... http://t.co/WB7KVO5

8 months ago...

Retweet

Favorite

Also Shared By:

Lipitor Met Its Match? Not So Fast, But AstraZeneca Gains Knowledge - QualityPoint Technologies

qualitypointtech.net — “Pharma giant AstraZeneca has declared that its cholesterol drug Crestor was not significantly better than Pfizer's Lipitor at preventing plaque from building up in one of the arteries that feed blood to the heart. However, AstraZeneca said in a news release that there was a trend toward better performance on Crestor and that using a different way of calculating the amount of plaque in the artery the difference was significant...” View full resource at qualitypointtech.net